#DBVT↓

DBVT/ 03/02/2026 · 11:09 AM

83% of Kids Tolerate More Peanut with VIASKIN Patch in Landmark Study

DBV Technologies reveals new VITESSE Phase 3 data at AAAAI 2026: 83% of kids on VIASKIN Peanut Patch increased safe peanut dose vs 48% on placebo, with excellent safety.

DBVT/ 12/16/2025 · 4:38 PM

Peanut Allergy Patch Shows 47% Success Rate in Children

DBV Technologies' (DBVT) VIASKIN Peanut patch shows significant success in treating peanut allergies in children aged 4-7, with nearly half of participants responding positively after one year.